Ascites regression following neoadjuvant chemotherapy in prediction of treatment outcome among stage IIIc to IV high-grade serous ovarian cancer

被引：0
|
作者：
Xia Xu
Fei Deng
Mengmeng Lv
Binhui Ren
Wenwen Guo
Xiaoxiang Chen
机构：
[1] Department of Chemotherapy,
[2] Jiangsu Cancer Hospital,undefined
[3] Department of Gynecologic Oncology,undefined
[4] Jiangsu Cancer Hospital,undefined
[5] Department of Thoracic Oncology,undefined
[6] Jiangsu Cancer Hospital,undefined
[7] The Second Affiliated Hospital of Nanjing Medical University,undefined
来源：
Journal of Ovarian Research | / 9卷
关键词：
High grade serous ovarian cancer; CA-125; Ascites; Primary debulking surgery; Interval debulking surgery;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Ascites regression following neoadjuvant chemotherapy in prediction of treatment outcome among stage IIIc to IV high-grade serous ovarian cancer
    Xu, Xia
    Deng, Fei
    Lv, Mengmeng
    Ren, Binhui
    Guo, Wenwen
    Chen, Xiaoxiang
    JOURNAL OF OVARIAN RESEARCH, 2016, 9
  • [2] The number of cycles of neoadjuvant chemotherapy is associated with prognosis of stage IIIc–IV high-grade serous ovarian cancer
    Xia Xu
    Fei Deng
    Mengmeng Lv
    Xiaoxiang Chen
    Archives of Gynecology and Obstetrics, 2017, 295 : 451 - 458
  • [3] The number of cycles of neoadjuvant chemotherapy is associated with prognosis of stage IIIc-IV high-grade serous ovarian cancer
    Xu, Xia
    Deng, Fei
    Lv, Mengmeng
    Chen, Xiaoxiang
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2017, 295 (02) : 451 - 458
  • [4] Tumor-infiltrating lymphocytes expression in stage IIIc/IV of high-grade serous ovarian cancer: Variation with neoadjuvant chemotherapy and prognostic value
    Barcena, C.
    Rojas, K.
    Lema, L.
    Manso Sanchez, L.
    Rios, J.
    Garcia-Martin, R.
    Maroto, A.
    Rodriguez-Peralto, J. L.
    Ciruelos Gil, E. M.
    Mendiola, D. C.
    Paz-Ares, L.
    ANNALS OF ONCOLOGY, 2017, 28
  • [5] NEOADJUVANT CHEMOTHERAPY IN THE COMPLEX TREATMENT OF PATIENTS WITH STAGE IIIC - IV OVARIAN CANCER
    Kryzhanivska, Anna
    Djakiv, Iryna
    Hrytsyk, Roman
    ANTICANCER RESEARCH, 2023, 43 (07) : 3377 - 3377
  • [6] New prognostic index for neoadjuvant chemotherapy outcome in patients with advanced high-grade serous ovarian cancer
    Huo, Chuying
    Wu, Bin
    Ye, Dongdong
    Xu, Miaochun
    Ma, Shaolin
    Cheng, Aoshuang
    Liu, Yunyun
    Huang, Chunxian
    Zhang, Yuhao
    Lin, Zhongqiu
    Li, Bowen
    Lu, Huaiwu
    BMC CANCER, 2024, 24 (01)
  • [7] Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
    Vergote, Ignace
    Trope, Claes G.
    Amant, Frederic
    Kristensen, Gunnar B.
    Ehlen, Tom
    Johnson, Nick
    Verheijen, Rene H. M.
    van der Burg, Maria E. L.
    Lacave, Angel J.
    Panici, Pierluigi Benedetti
    Kenter, Gemma G.
    Casado, Antonio
    Mendiola, Cesar
    Coens, Corneel
    Verleye, Leen
    Stuart, Gavin C. E.
    Pecorelli, Sergio
    Reed, Nick S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (10): : 943 - 953
  • [8] Potential risk factors associated with prognosis of neoadjuvant chemotherapy followed by interval debulking surgery in stage IIIc-IV high-grade serous ovarian carcinoma patients
    Zhang, Jie
    Liu, Ning
    Zhang, Aihong
    Bao, Xiangxiang
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2018, 44 (09) : 1808 - 1816
  • [9] Neoadjuvant treatment as a window to chemotherapy driven alterations to the genome and transcriptome of high-grade serous ovarian cancer
    Javellana, Melissa
    Eckert, Mark
    Stock, Elizabeth
    Chapel, David
    Lastra, Ricardo
    Lengyel, Ernst
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S210 - S210
  • [10] Neoadjuvant Chemotherapy Is the Better Treatment Option in Some Patients With Stage IIIc to IV Ovarian Cancer
    Vergote, Ignace
    Trope, Claes G.
    Amant, Frederic
    Ehlen, Tom
    Reed, Nick S.
    Casado, Antonio
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (31) : 4076 - 4078
12345